Markets › India › BOM › CORALAB

Coral Laboratories Limited

BOM:CORALABHealthcare

₹524.80−1.70%At closeAt close · Tue 20 Oct · ≈ AED 20.28 · Market cap $20.07M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	43.6%	41.8%	36.8%	50.9%	39.3%	37.6%	—	—
Operating margin	14.6%	8.5%	2.1%	17.4%	21.1%	15.2%	15.2%	+0.0 pts
Net margin	14.2%	12.4%	8.3%	19.2%	21.0%	19.1%	19.1%	+0.0 pts
EBITDA margin	20.9%	19.1%	13.8%	27.7%	30.1%	29.6%	—	—
Return on equity	9.9%	5.8%	4.2%	8.9%	12.0%	7.8%	7.8%	+0.0 pts
Return on assets	8.1%	4.8%	3.7%	7.7%	10.5%	6.8%	6.8%	+0.0 pts
Return on capital employed	9.9%	3.8%	1.0%	7.9%	11.8%	6.1%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	3.7%	3.2%	0.0%	0.0%	1.6%	1.8%	—	—
Interest coverage	326.3×	44.1×	4.8×	71,318.0×	248.2×	76.3×	—	—
Current ratio	4.7×	5.1×	10.4×	6.2×	7.1×	6.5×	6.5×	+0.0%
Quick ratio	3.9×	4.4×	9.4×	5.6×	6.7×	5.7×	—	—
Cash ratio	0.1×	0.1×	0.5×	0.1×	0.1×	2.7×	2.7×	+0.0%
Asset turnover	0.6×	0.4×	0.4×	0.4×	0.5×	0.4×	—	—
Inventory turnover	2.5×	2.3×	3.9×	2.7×	7.1×	2.6×	—	—
Receivables turnover	143.4×	1.9×	385.4×	2.9×	3.4×	2.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	3.0%	3.3%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.